Sanofi in Consumer Health

May 2023

Sanofi maintained fourth position in consumer health in 2022 , with its strong brands in analgesics and cough cold and allergy remedies positively affected by growing self-treatment during the pandemic and cold season. The ongoing strategic divesture and spin-off aim to accelerate the future growth of its consumer health business. The recent leadership nominations and investment in digitalisation give an indication of Sanofi’s future direction in Asia Pacific.

USD 570
Request More Information


Files are delivered directly into your account soon after payment is received and any tax certification is verified (where applicable).

This report comes in PPT.


Euromonitor International's report on Sanofi delivers a detailed strategic analysis of the company's business, examining its performance in the Consumer Health market and the global economy. Company and market share data provide a detailed look at the financial position of Sanofi, while in-depth qualitative analysis will help you understand the brand strategy and growth prospects of Sanofi.

This report examines:

  • Company share by region and sector
  • Brand portfolio
  • New product developments
  • Marketing and distribution strategies

A detailed SWPT analysis of Sanofi provides strategic intelligence on:

  • Strengths and weaknesses
  • Category and country opportunities for growth
  • Challenges and threats from current competition and future prospects
  • Global and regional market positions

Research you can trust:

Euromonitor International's company profile reports are written by our Consumer Health research team, a dedicated group of analysts that knows the industry inside and out. Buy this report to inform your planning, strategy, marketing, sales and competitor intelligence functions.

Executive summary
Sanofi ranks fourth in global consumer health
Sanofi’s global footprint
Company overview
Disposal of non-core brands negatively affect Sanofi’s sales
New leadership to add fresh perspectives on transformation and break the bottleneck
Largest competitive overlaps come from rivals in the US OTC market
Key categories and markets
Doliprane and Dorflex are leading brands in France and Brazil
Latin America to drive future growth of Sanofi
Sanofi seeks opportunities in China through local partnerships
Sanofi witnessed its fastest growth in Latin America, owing to surging analgesics demand
Sanofi launches new analgesic formats to consolidate local market position
The Middle East and Africa and Latin America saw strong growth over 2019-2022
Allegra and Alesion saw recovery as outdoor activities revived in Japan
Executive summary
Projected company sales: FAQs
Projected company sales: FAQs

Consumer Health

It is the aggregation of OTC, Vitamins and Dietary Supplements (VDS), Sports Nutrition, and Weight Management and Wellbeing

See All of Our Definitions

Why buy this report:

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions


If you purchase a report that is updated in the next 60 days, we will send you the new edition and data extraction Free!